Topical vapocoolant spray in reducing the pain of intravenous cannulation in the emergency department: a randomised, single-blinded, placebo-controlled trial

Phase 3

Completed

• Conditions: Pain of intravenous cannulation; Anaesthesiology - Anaesthetics

• Registration Number: ACTRN12607000470493
• Lead Sponsor: Austin Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-09-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Emergency department patients, aged 18 years or more, requiring intravenous cannulation.

Exclusion Criteria

Refusal to provide consent; Inability to provide informed consent (Non-English speaking, altered mental state, significant illness); Moderate to severe discomfort or pain; Diseases of the skin associated with cold intolerance (eg: Raynaud’s phenomenon); Known allergy to spray contents; Peripheral neuropathy; Parenteral analgesia in the previous 4 hours

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain score of intravenous cannulation (0-100) on a visual analogue scale[One minute after cannulation]

Secondary Outcome Measures

Name	Time	Method
Thrombophlebitis, blistering, frostbite, redness, and swelling at the cannulation site[Five days after cannulation]